(Q37809052)

23 August 2017

Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events (English)

1 reference

23 August 2017

4

Christian Toso

1 reference

23 August 2017

Stéphanie Lacotte

1

1 reference

23 August 2017

Thierry Berney

series ordinal

2

1 reference

23 August 2017

Am James Shapiro

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

12 November 2010

1 reference

Expert Opinion on Biological Therapy

23 August 2017

1 reference

23 August 2017

11

1 reference

23 August 2017

1

1 reference

23 August 2017

55-66

1 reference

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

23 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Five-year follow-up after clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Recovery from diabetes in mice by beta cell regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Autoantibody response to islet transplantation in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Positron emission tomography in clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Factors affecting human islet of Langerhans isolation yields

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Organ preservation in pancreas and islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Comparison of modified Celsior solution and M-kyoto solution for pancreas preservation in human islet isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Extracellular matrix protects pancreatic beta-cells against apoptosis: role of short- and long-term signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Blockade of beta1 integrin-laminin-5 interaction affects spreading and insulin secretion of rat beta-cells attached on extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Resolvin E1 reduces proinflammatory markers in human pancreatic islets in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Optimal implantation site for pancreatic islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO-compatible blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Innate immunity and heat shock response in islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

The role of macrophage migration inhibitory factor in mouse islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Allosensitization of islet allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and IV immunoglobulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Using an immune functional assay to differentiate acute cellular rejection from recurrent hepatitis C in liver transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Molecular detection of circulating beta-cells after islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Activated effector and memory T cells contribute to circulating sCD30: potential marker for islet allograft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Tuning immune responses: diversity and adaptation of the immunological synapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Positron-emission tomography imaging of early events after transplantation of islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Visualization of early engraftment in clinical islet transplantation by positron-emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Integrins and extracellular matrices in pancreatic tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Pre-transplant IFN-gamma ELISPOTs are associated with post-transplant renal function in African American renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

Quality of Life After Islet Transplant: Impact of the Number of Islet Infusions and Metabolic Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.536530

10.1517/14712598.2011.536530

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference